Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2018 Jan 4;54(9):765–770. doi: 10.1007/s13312-017-1172-5

Hepatic sinusoidal-obstruction syndrome and busulfan-induced lung injury in a post-autologous stem cell transplant recipient

Richa Jain 1, Kirti Gupta 2,✉, Anmol Bhatia 3, Arun Bansal 1, Deepak Bansal 1
PMCID: PMC7097441  PMID: 28984258

Abstract

Veno-occlusive disease of the liver is mostly encountered as a complication of hematopoietic stem cell transplantation with myeloablative regimens with an incidence estimated to be 13.7%. It is clinically characterized by tender hepatomegaly, jaundice, weight gain and ascites. Strong clinical suspicion and an early recognition of clinical signs are essential to establish the diagnosis and institute effective regimen. Another complication of cytotoxic drugs given for cancers, is development of busulfan-induced lung injury. A strong index of suspicion is needed for its diagnosis, especially in setting where opportunistic fungal and viral infections manifest similarly. We illustrate the clinical and autopsy finings in a 2½-year-old boy who received autologous stem-cell transplantation following resection of stage IV neuroblastoma. He subsequently developed both hepatic veno-occlusive disease and busulfan-induced lung injury. The autopsy findings are remarkable for their rarity.

Keywords: Autopsy, Hepatic veno-occlusive disease, Neuroblastoma

References

  • 1.McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Internal Med. 1993;118:255–67. doi: 10.7326/0003-4819-118-4-199302150-00003. [DOI] [PubMed] [Google Scholar]
  • 2.Jha AK, Bansal D, Chakrabarti A, Shivaprakash MR, Trehan A, Marwaha RK. Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies. Mycoses. 2013;56:442–8. doi: 10.1111/myc.12048. [DOI] [PubMed] [Google Scholar]
  • 3.Fan CQ, Crawford JM. Sinusoidal obstruction syndrome (hepatic veno-occlusivedisease) J Clin Exp Hepatol. 2014;4:332–46. doi: 10.1016/j.jceh.2014.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kumar S, DeLeve LD, Kamath PS, Tefferi A. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc. 2003;78:589–98. doi: 10.4065/78.5.589. [DOI] [PubMed] [Google Scholar]
  • 5.Valla DC, Cazals-Hatem D. Clin Res Hepatol Gastroenterol. 2016. Sinusoidal obstruction syndrome. [DOI] [PubMed] [Google Scholar]
  • 6.DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. American Association for the Study Liver Diseases. Hepatology. 2009;49:1729–64. doi: 10.1002/hep.22772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Carreras E, Bertz H, Arcese W, Vernant JP, Tomás JF, Hagglund H, et al. Incidence and outcome of hepatic venoocclusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood. 1998;92:3599–604. [PubMed] [Google Scholar]
  • 8.Salat C, Holler E, Kolb HJ, Pihusch R, Reinhardt B, Penovici M, et al. The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation. Leuk Lymphoma. 1999;33:25–32. doi: 10.3109/10428199909093722. [DOI] [PubMed] [Google Scholar]
  • 9.Nürnberger W, Michelmann I, Burdach S, Göbel U. Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications. Ann Hematol. 1998;76:61–5. doi: 10.1007/s002770050364. [DOI] [PubMed] [Google Scholar]
  • 10.Cutler C, Kim HT, Ayanian S, Bradwin G, Revta C, Aldridge J, et al. Prediction of veno-occlusive disease using biomarkers of endothelial injury. Biol Blood Marrow Transplant. 2010;16:1180–5. doi: 10.1016/j.bbmt.2010.02.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984;4:116–22. doi: 10.1002/hep.1840040121. [DOI] [PubMed] [Google Scholar]
  • 12.Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44:778–83. doi: 10.1097/00007890-198712000-00011. [DOI] [PubMed] [Google Scholar]
  • 13.Oakhill A, Green I K G A S K H F, et al. Busulphan lung in childhood. J Clin Pathol. 1981;34:495. doi: 10.1136/jcp.34.5.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lund MB, Brinch L, Kongerud J, Boe J. Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide. Eur Respir J. 2004;23:901. doi: 10.1183/09031936.04.00084804. [DOI] [PubMed] [Google Scholar]
  • 15.Vergnon JM, Boucheron S, Riffat J, Guy C, Blanc P, Emonot A. Interstitial pneumopathies caused by busulfan. Histologic, developmental and bronchoalveolar lavage analysis of 3 cases. Rev Med Interne. 1988;9:377. doi: 10.1016/S0248-8663(88)80137-1. [DOI] [PubMed] [Google Scholar]

Articles from Indian Pediatrics are provided here courtesy of Nature Publishing Group

RESOURCES